Type II

Tirzepatide Shows Benefits in Type 2 Patients

Tirzepatide, a newer diabetes drug, has been shown to reduce patient hemoglobin A1c levels, as well as lowering body weight and improving insulin sensitivity markers in patients with type 2 diabetes.  Read more

Weight Loss or Physical Activity – is One More Important for Preventing Type 2?

The US Diabetes Prevention Program (DPP) multicenter trial established nearly 20 years ago that it is possible to delay or prevent prediabetes from progressing into full-blown type 2 diabetes. The DPP trial places greater emphasis on weight loss over physical activity, but is that emphasis in the right place? Diabetes exercise expert Dr. Sheri Colberg examines […]

Women with PCOS & Obesity at Greater Risk for Type 2

Women who have obesity and polycystic ovarian syndrome (PCOS) have an increased risk of developing type 2 diabetes, researchers say. PCOS is experienced by up to 10% of women of reproductive age, and between 50% and 80% of women with PCOS have obesity. Read more

Type 2 Diabetes Linked to Parkinson’s Disease

Researchers say there is convincing evidence that people with type 2 diabetes have an increased risk of developing Parkinson’s disease. Type 2 diabetes is also linked to faster disease progression in patients who already have Parkinson’s. Read more

Timing of Exercise May Affect Its Benefits for Men

Researchers say the time of day at which men with type 2 diabetes and obesity or overweight performed moderate-to-vigorous physical activity made a difference in their cardiovascular fitness and health risks. They did not find the same effect in women who participated in the study. Read more

The “Medication Burden” and Type 2 Diabetes

People who have type 2 diabetes are likely to have complicated medication regimens that involve taking multiple drugs (also known as polypharmacy). Complex medication regimens are associated with worse health outcomes, as it is more difficult to follow a complicated treatment correctly, and there is increased risk for drug interactions. Read more

Should Type 2 Diabetes Screening Begin at 35?

It’s currently recommended that people with overweight or obesity be screened for type 2 diabetes beginning at age 40. A new draft set of guidelines from the U.S. Preventive Services Task Force recommends the age be lowered to 35, due to the high levels of overweight and obesity in Americans. Read more

Researchers Seek Potential New Obesity & Type 2 Drug

GIP and GLP-1 are substances produced in the body’s digestive tract, and they play important roles in regulating body weight and food intake. A recently published study on their effects suggests that they may one day be used to develop drugs to treat obesity and type 2 diabetes. Read more

High Glucose Can Damage the Brain

Uncontrolled blood glucose in diabetes can lead to numerous debilitating complications, including high blood pressure, strokes, slow wound healing, and possibly amputations. Researchers have found that brain damage can also result from uncontrolled type 2 diabetes. Read more

Your Ethnicity Affects Your Risk for Diabetes Complications

Chronic kidney disease and cardiovascular disease are both common complications of type 2 diabetes. However, your risk of developing these complications can be impacted by various factors, including your ethnic background. Read more 

Metformin Can Improve Surgical Recovery

Metformin, a commonly-prescribed diabetes drug, may have other benefits, researchers say. A study found that metformin use in patients with type 2 diabetes is associated with a reduced risk of rehospitalization and death following surgery. Read more

Start Combination Therapy Earlier, ADA Says

Metformin is the typical first-line treatment for people with type 2 diabetes, but the ADA suggests early combination therapy with other medications should be used in patients with type 2 diabetes and chronic kidney disease or cardiovascular disease. Read more

Weight at Birth Linked to Type 2 Risk

A birthweight of 2.5 kg (about 5.5 pounds) or more is linked to increased risk of developing type 2 diabetes later in life, researchers say. A person’s susceptibility to type 2 diabetes is determined by various risk factors over the course of their lives. Read more

For COVID-19 Mortality, Type 2 Diabetes “Adds 20 Years” to Age

The risk of dying from COVID-19 infection is higher in middle-aged adults with type 2 diabetes versus adults without diabetes, and is the equivalent of adding 20 years of chronological age in assessing overall related death risk. Read more

Does Your Pet’s Diabetes Increase Your Own Risk?

Having a dog that is diagnosed with diabetes was related to a increased risk of type 2 diabetes in the owner, a recent study found. Potential causes of this link in dog-owner pairs might possibly have something to do with shared health habits, such as physical activity level, and shared environmental exposures. Read more

Social Deprivation Increases Risk for Diabetic Foot Complications

People who suffer from social deprivation, which can be caused by factors including poverty and mental illness, and who have type 2 diabetes are at greater risk for complications of diabetic foot disease, including diabetic foot ulcers, lower limb amputation, and gangrene. Read more

The Role of Weak and Strong Cells in Insulin Production

Type 2 diabetes is the condition that results when β-cells (beta cells) cannot release enough insulin for the body’s needs. A group of researchers say they have new insight into how “weak” beta cells bond with other, more mature cells to boost insulin production, which can help us understand more about the processes that lead […]

Type 2 Increases Liver Disease Risk

Some metabolic conditions, including type 2 diabetes, can increase the risk of severe non-alcoholic fatty liver disease (NAFLD), a condition which can cause inflammation, cirrhosis, and possibly liver cancer. People with type 2 diabetes have twice the risk of severe liver disease than people without type 2, researchers say. Read more

Add-on Therapy Can Reduce Insulin Use for Type 2 Patients

Insulin is the mainstay treatment for patients with type 2 diabetes who also have beta-cell failure; however, some insulin regimens can be complicated to manage and may increase the risk of hypoglycemia. Now, researchers say that a simple add-on therapy with the GLP-1 Agonist medication albiglutide can reduce insulin use for patients with type 2 […]

Can Potatoes Be Part of a Diabetes-Friendly Diet?

Limiting intake of high-carbohydrate foods like pasta, breads and potatoes, has long been a staple of diabetes lifestyle management. However, a recent study of people with type two diabetes suggests that eating white potatoes may not be incompatible with a healthy diabetes diet after all, as consuming potatoes did not affect the study participants’ blood […]